Rigel Pharmaceuticals

$3.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-1.81%) Today

-$0.01 (-0.31%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RIGL and other stocks, options, and ETFs commission-free!

About RIGL

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.

CEO

Raul R. Rodriguez

Employees

169

Headquarters

South San Francisco, California

Founded

1996

Market Cap

557.68M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.89M

High Today

$3.30

Low Today

$3.22

Open Price

$3.30

Volume

1.53M

52 Week High

$5.50

52 Week Low

$1.45

RIGL Earnings

-$0.13

-$0.04

$0.04

$0.13

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 4, After Hours